HY-103347-5mg
|
MedChemexpress LLC
|
M50054 [CAS 54135-60-3]
|
|
COVID-19-immunoregulation
|
|
HY-108738-1mg
|
MedChemexpress LLC
|
Daclizumab [CAS 152923-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-108738-10mg
|
MedChemexpress LLC
|
Daclizumab [CAS 152923-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-108738-5mg
|
MedChemexpress LLC
|
Daclizumab [CAS 152923-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-108810-1mg
|
MedChemexpress LLC
|
Canakinumab [CAS 914613-48-2]
|
|
COVID-19-immunoregulation
|
|
HY-108810-5mg
|
MedChemexpress LLC
|
Canakinumab [CAS 914613-48-2]
|
|
COVID-19-immunoregulation
|
|
HY-108831-10mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-108831-25mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-108831-5mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-108852-1mg
|
MedChemexpress LLC
|
Basiliximab [CAS 179045-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-108852-10mg
|
MedChemexpress LLC
|
Basiliximab [CAS 179045-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-108852-5mg
|
MedChemexpress LLC
|
Basiliximab [CAS 179045-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109714-100mg
|
MedChemexpress LLC
|
3,4-Benzocoumarin [CAS 2005-10-9]
|
|
COVID-19-immunoregulation
|
|
HY-109714-50mg
|
MedChemexpress LLC
|
3,4-Benzocoumarin [CAS 2005-10-9]
|
|
COVID-19-immunoregulation
|
|
HY-114697-10mg
|
MedChemexpress LLC
|
DSG Crosslinker [CAS 79642-50-5]
|
|
COVID-19-immunoregulation
|
|
HY-114697-100mg
|
MedChemexpress LLC
|
DSG Crosslinker [CAS 79642-50-5]
|
|
COVID-19-immunoregulation
|
|
HY-114697-5mg
|
MedChemexpress LLC
|
DSG Crosslinker [CAS 79642-50-5]
|
|
COVID-19-immunoregulation
|
|
HY-114697-50mg
|
MedChemexpress LLC
|
DSG Crosslinker [CAS 79642-50-5]
|
|
COVID-19-immunoregulation
|
|
HY-114816-100mg
|
MedChemexpress LLC
|
N-Butanoyl-L-homoserine lactone [CAS 67605-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-114816-50mg
|
MedChemexpress LLC
|
N-Butanoyl-L-homoserine lactone [CAS 67605-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-114995-1g
|
MedChemexpress LLC
|
Tr-PEG2-OH [CAS 105589-77-3]
|
|
COVID-19-immunoregulation
|
|
HY-114995-5g
|
MedChemexpress LLC
|
Tr-PEG2-OH [CAS 105589-77-3]
|
|
COVID-19-immunoregulation
|
|
HY-115374-100mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-250mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-50mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|